Loading…

Phylogenetic Groups of Escherichia coli Strains from Patients with Urinary Tract Infection in Iran Based on the New Clermont Phylotyping Method

Objectives. In 2013, Clermont classified E. coli strains into eight phylogenetic groups using a new quadruplex PCR method. The aims of this study were to identify the phylogenetic groups of E. coli based on this method and to assess their antibiotic resistance patterns in Bushehr, Iran. Methods. In...

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international 2015-01, Vol.2015 (2015), p.1-7
Main Authors: Khamisipour, Gholamreza, Tajbakhsh, Saeed, Ansari, Hossein, Hassanpour, Mojtaba, Iranpour, Darioush, Najafi, Akram
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c491t-25179594a7f76699d7265e3250ec439d8a0adde6752e528a9404cc5f1e2703da3
cites cdi_FETCH-LOGICAL-c491t-25179594a7f76699d7265e3250ec439d8a0adde6752e528a9404cc5f1e2703da3
container_end_page 7
container_issue 2015
container_start_page 1
container_title BioMed research international
container_volume 2015
creator Khamisipour, Gholamreza
Tajbakhsh, Saeed
Ansari, Hossein
Hassanpour, Mojtaba
Iranpour, Darioush
Najafi, Akram
description Objectives. In 2013, Clermont classified E. coli strains into eight phylogenetic groups using a new quadruplex PCR method. The aims of this study were to identify the phylogenetic groups of E. coli based on this method and to assess their antibiotic resistance patterns in Bushehr, Iran. Methods. In this cross-sectional study, 140 E. coli isolates were subjected to phylogenetic typing by a quadruplex PCR method. Antimicrobial susceptibility testing was performed by disk diffusion method. Results. Phylogenetic group B2 was most predominant (39.3%), followed by unknown (27.1%), E (9.3%), C and clade I (each 6.4%), B1 (5%), F and D (each 2.9%), and A (0.7%). The most common antibiotic resistance was related to amoxicillin (82.1%) and the least to meropenem (0.7%). 82.14% of isolates were multiple drug resistant (MDR). Antibiotic resistance was mainly detected in group B2 (50%). Conclusions. Our findings showed the high prevalence of MDR E. coli isolates with dominance of group B2. About 25% of E. coli isolates belong to the newly described phylogroups C, E, F, and clade I. Such studies need to be done also in other regions to provide greater understanding of the antibiotic resistance pattern and the prevalences of different phylogenetic groups.
doi_str_mv 10.1155/2015/846219
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4322292</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A458163564</galeid><sourcerecordid>A458163564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-25179594a7f76699d7265e3250ec439d8a0adde6752e528a9404cc5f1e2703da3</originalsourceid><addsrcrecordid>eNqNkk9rFDEYhwdRbKk9eZeAF1HW5v9MLkJdal2oWrA9h5h5ZydlJtkmGZf9FH5ls25dVk_NJSF5eJL3za-qXhL8nhAhzigm4qzhkhL1pDqmjPCZJJw83a8ZO6pOU7rDZTREYiWfV0dUSEUJr4-rX9f9ZghL8JCdRZcxTKuEQocuku0hOts7g2wYHPqeo3E-oS6GEV2b7MDnhNYu9-g2Om_iBt1EYzNa-A5sdsEj59EiGo8-mgQtKhu5B_QV1mg-QByDz-jP5Xmzcn6JvkDuQ_uietaZIcHpw3xS3X66uJl_nl19u1zMz69mliuSZ1SQWgnFTd3VUirV1lQKYFRgsJyptjHYtC3IWlAQtDGKY26t6AjQGrPWsJPqw867mn6M0NpSTTSDXkU3llJ0ME7_e-Jdr5fhp-aMUqpoEbx5EMRwP0HKenTJwjAYD2FKmkjZUN5QSh6BipqRRlJW0Nf_oXdhir50YktRRrHCB9TSDKCd70J5ot1K9TkX5ZeZkLxQ73aUjSGlCN2-OoL1Njx6Gx69C0-hXx02ZM_-jUoB3u6A3vnWrN3jbFAQ6MwBXHy1ZL8BQ8PU6Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1652320903</pqid></control><display><type>article</type><title>Phylogenetic Groups of Escherichia coli Strains from Patients with Urinary Tract Infection in Iran Based on the New Clermont Phylotyping Method</title><source>Access via ProQuest (Open Access)</source><source>Wiley Online Library (Open Access Collection)</source><creator>Khamisipour, Gholamreza ; Tajbakhsh, Saeed ; Ansari, Hossein ; Hassanpour, Mojtaba ; Iranpour, Darioush ; Najafi, Akram</creator><contributor>Chao, Yun-Peng</contributor><creatorcontrib>Khamisipour, Gholamreza ; Tajbakhsh, Saeed ; Ansari, Hossein ; Hassanpour, Mojtaba ; Iranpour, Darioush ; Najafi, Akram ; Chao, Yun-Peng</creatorcontrib><description>Objectives. In 2013, Clermont classified E. coli strains into eight phylogenetic groups using a new quadruplex PCR method. The aims of this study were to identify the phylogenetic groups of E. coli based on this method and to assess their antibiotic resistance patterns in Bushehr, Iran. Methods. In this cross-sectional study, 140 E. coli isolates were subjected to phylogenetic typing by a quadruplex PCR method. Antimicrobial susceptibility testing was performed by disk diffusion method. Results. Phylogenetic group B2 was most predominant (39.3%), followed by unknown (27.1%), E (9.3%), C and clade I (each 6.4%), B1 (5%), F and D (each 2.9%), and A (0.7%). The most common antibiotic resistance was related to amoxicillin (82.1%) and the least to meropenem (0.7%). 82.14% of isolates were multiple drug resistant (MDR). Antibiotic resistance was mainly detected in group B2 (50%). Conclusions. Our findings showed the high prevalence of MDR E. coli isolates with dominance of group B2. About 25% of E. coli isolates belong to the newly described phylogroups C, E, F, and clade I. Such studies need to be done also in other regions to provide greater understanding of the antibiotic resistance pattern and the prevalences of different phylogenetic groups.</description><identifier>ISSN: 2314-6133</identifier><identifier>ISSN: 2314-6141</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2015/846219</identifier><identifier>PMID: 25692147</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents - pharmacology ; Antibiotics ; Antimicrobial agents ; Bacteriology ; Child ; Child, Preschool ; Cross-Sectional Studies ; Drug resistance ; Drug Resistance, Microbial - drug effects ; Drug Resistance, Microbial - genetics ; Drug Resistance, Multiple, Bacterial - drug effects ; Drug Resistance, Multiple, Bacterial - genetics ; E coli ; Escherichia coli ; Escherichia coli - drug effects ; Escherichia coli - genetics ; Escherichia coli - isolation &amp; purification ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - microbiology ; Female ; Humans ; Identification and classification ; Infant ; Infections ; Iran ; Laboratories ; Male ; Methods ; Microbial Sensitivity Tests - methods ; Middle Aged ; Phylogenetics ; Phylogeny ; Physiological aspects ; Science ; Studies ; Surveillance ; Urinary tract diseases ; Urinary tract infections ; Urinary Tract Infections - drug therapy ; Urinary Tract Infections - microbiology ; Urogenital system ; Young Adult</subject><ispartof>BioMed research international, 2015-01, Vol.2015 (2015), p.1-7</ispartof><rights>Copyright © 2015 Darioush Iranpour et al.</rights><rights>COPYRIGHT 2015 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2015 Darioush Iranpour et al. Darioush Iranpour et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2015 Darioush Iranpour et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-25179594a7f76699d7265e3250ec439d8a0adde6752e528a9404cc5f1e2703da3</citedby><cites>FETCH-LOGICAL-c491t-25179594a7f76699d7265e3250ec439d8a0adde6752e528a9404cc5f1e2703da3</cites><orcidid>0000-0003-3009-6579 ; 0000-0002-8308-6115 ; 0000-0003-3752-6033 ; 0000-0001-6023-3939 ; 0000-0002-5773-9012 ; 0000-0002-9928-7261</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1652320903/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1652320903?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25692147$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Chao, Yun-Peng</contributor><creatorcontrib>Khamisipour, Gholamreza</creatorcontrib><creatorcontrib>Tajbakhsh, Saeed</creatorcontrib><creatorcontrib>Ansari, Hossein</creatorcontrib><creatorcontrib>Hassanpour, Mojtaba</creatorcontrib><creatorcontrib>Iranpour, Darioush</creatorcontrib><creatorcontrib>Najafi, Akram</creatorcontrib><title>Phylogenetic Groups of Escherichia coli Strains from Patients with Urinary Tract Infection in Iran Based on the New Clermont Phylotyping Method</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Objectives. In 2013, Clermont classified E. coli strains into eight phylogenetic groups using a new quadruplex PCR method. The aims of this study were to identify the phylogenetic groups of E. coli based on this method and to assess their antibiotic resistance patterns in Bushehr, Iran. Methods. In this cross-sectional study, 140 E. coli isolates were subjected to phylogenetic typing by a quadruplex PCR method. Antimicrobial susceptibility testing was performed by disk diffusion method. Results. Phylogenetic group B2 was most predominant (39.3%), followed by unknown (27.1%), E (9.3%), C and clade I (each 6.4%), B1 (5%), F and D (each 2.9%), and A (0.7%). The most common antibiotic resistance was related to amoxicillin (82.1%) and the least to meropenem (0.7%). 82.14% of isolates were multiple drug resistant (MDR). Antibiotic resistance was mainly detected in group B2 (50%). Conclusions. Our findings showed the high prevalence of MDR E. coli isolates with dominance of group B2. About 25% of E. coli isolates belong to the newly described phylogroups C, E, F, and clade I. Such studies need to be done also in other regions to provide greater understanding of the antibiotic resistance pattern and the prevalences of different phylogenetic groups.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacteriology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cross-Sectional Studies</subject><subject>Drug resistance</subject><subject>Drug Resistance, Microbial - drug effects</subject><subject>Drug Resistance, Microbial - genetics</subject><subject>Drug Resistance, Multiple, Bacterial - drug effects</subject><subject>Drug Resistance, Multiple, Bacterial - genetics</subject><subject>E coli</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - isolation &amp; purification</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Female</subject><subject>Humans</subject><subject>Identification and classification</subject><subject>Infant</subject><subject>Infections</subject><subject>Iran</subject><subject>Laboratories</subject><subject>Male</subject><subject>Methods</subject><subject>Microbial Sensitivity Tests - methods</subject><subject>Middle Aged</subject><subject>Phylogenetics</subject><subject>Phylogeny</subject><subject>Physiological aspects</subject><subject>Science</subject><subject>Studies</subject><subject>Surveillance</subject><subject>Urinary tract diseases</subject><subject>Urinary tract infections</subject><subject>Urinary Tract Infections - drug therapy</subject><subject>Urinary Tract Infections - microbiology</subject><subject>Urogenital system</subject><subject>Young Adult</subject><issn>2314-6133</issn><issn>2314-6141</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkk9rFDEYhwdRbKk9eZeAF1HW5v9MLkJdal2oWrA9h5h5ZydlJtkmGZf9FH5ls25dVk_NJSF5eJL3za-qXhL8nhAhzigm4qzhkhL1pDqmjPCZJJw83a8ZO6pOU7rDZTREYiWfV0dUSEUJr4-rX9f9ZghL8JCdRZcxTKuEQocuku0hOts7g2wYHPqeo3E-oS6GEV2b7MDnhNYu9-g2Om_iBt1EYzNa-A5sdsEj59EiGo8-mgQtKhu5B_QV1mg-QByDz-jP5Xmzcn6JvkDuQ_uietaZIcHpw3xS3X66uJl_nl19u1zMz69mliuSZ1SQWgnFTd3VUirV1lQKYFRgsJyptjHYtC3IWlAQtDGKY26t6AjQGrPWsJPqw867mn6M0NpSTTSDXkU3llJ0ME7_e-Jdr5fhp-aMUqpoEbx5EMRwP0HKenTJwjAYD2FKmkjZUN5QSh6BipqRRlJW0Nf_oXdhir50YktRRrHCB9TSDKCd70J5ot1K9TkX5ZeZkLxQ73aUjSGlCN2-OoL1Njx6Gx69C0-hXx02ZM_-jUoB3u6A3vnWrN3jbFAQ6MwBXHy1ZL8BQ8PU6Q</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Khamisipour, Gholamreza</creator><creator>Tajbakhsh, Saeed</creator><creator>Ansari, Hossein</creator><creator>Hassanpour, Mojtaba</creator><creator>Iranpour, Darioush</creator><creator>Najafi, Akram</creator><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3009-6579</orcidid><orcidid>https://orcid.org/0000-0002-8308-6115</orcidid><orcidid>https://orcid.org/0000-0003-3752-6033</orcidid><orcidid>https://orcid.org/0000-0001-6023-3939</orcidid><orcidid>https://orcid.org/0000-0002-5773-9012</orcidid><orcidid>https://orcid.org/0000-0002-9928-7261</orcidid></search><sort><creationdate>20150101</creationdate><title>Phylogenetic Groups of Escherichia coli Strains from Patients with Urinary Tract Infection in Iran Based on the New Clermont Phylotyping Method</title><author>Khamisipour, Gholamreza ; Tajbakhsh, Saeed ; Ansari, Hossein ; Hassanpour, Mojtaba ; Iranpour, Darioush ; Najafi, Akram</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-25179594a7f76699d7265e3250ec439d8a0adde6752e528a9404cc5f1e2703da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacteriology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cross-Sectional Studies</topic><topic>Drug resistance</topic><topic>Drug Resistance, Microbial - drug effects</topic><topic>Drug Resistance, Microbial - genetics</topic><topic>Drug Resistance, Multiple, Bacterial - drug effects</topic><topic>Drug Resistance, Multiple, Bacterial - genetics</topic><topic>E coli</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - isolation &amp; purification</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Female</topic><topic>Humans</topic><topic>Identification and classification</topic><topic>Infant</topic><topic>Infections</topic><topic>Iran</topic><topic>Laboratories</topic><topic>Male</topic><topic>Methods</topic><topic>Microbial Sensitivity Tests - methods</topic><topic>Middle Aged</topic><topic>Phylogenetics</topic><topic>Phylogeny</topic><topic>Physiological aspects</topic><topic>Science</topic><topic>Studies</topic><topic>Surveillance</topic><topic>Urinary tract diseases</topic><topic>Urinary tract infections</topic><topic>Urinary Tract Infections - drug therapy</topic><topic>Urinary Tract Infections - microbiology</topic><topic>Urogenital system</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khamisipour, Gholamreza</creatorcontrib><creatorcontrib>Tajbakhsh, Saeed</creatorcontrib><creatorcontrib>Ansari, Hossein</creatorcontrib><creatorcontrib>Hassanpour, Mojtaba</creatorcontrib><creatorcontrib>Iranpour, Darioush</creatorcontrib><creatorcontrib>Najafi, Akram</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khamisipour, Gholamreza</au><au>Tajbakhsh, Saeed</au><au>Ansari, Hossein</au><au>Hassanpour, Mojtaba</au><au>Iranpour, Darioush</au><au>Najafi, Akram</au><au>Chao, Yun-Peng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phylogenetic Groups of Escherichia coli Strains from Patients with Urinary Tract Infection in Iran Based on the New Clermont Phylotyping Method</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>2015</volume><issue>2015</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>2314-6133</issn><issn>2314-6141</issn><eissn>2314-6141</eissn><abstract>Objectives. In 2013, Clermont classified E. coli strains into eight phylogenetic groups using a new quadruplex PCR method. The aims of this study were to identify the phylogenetic groups of E. coli based on this method and to assess their antibiotic resistance patterns in Bushehr, Iran. Methods. In this cross-sectional study, 140 E. coli isolates were subjected to phylogenetic typing by a quadruplex PCR method. Antimicrobial susceptibility testing was performed by disk diffusion method. Results. Phylogenetic group B2 was most predominant (39.3%), followed by unknown (27.1%), E (9.3%), C and clade I (each 6.4%), B1 (5%), F and D (each 2.9%), and A (0.7%). The most common antibiotic resistance was related to amoxicillin (82.1%) and the least to meropenem (0.7%). 82.14% of isolates were multiple drug resistant (MDR). Antibiotic resistance was mainly detected in group B2 (50%). Conclusions. Our findings showed the high prevalence of MDR E. coli isolates with dominance of group B2. About 25% of E. coli isolates belong to the newly described phylogroups C, E, F, and clade I. Such studies need to be done also in other regions to provide greater understanding of the antibiotic resistance pattern and the prevalences of different phylogenetic groups.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>25692147</pmid><doi>10.1155/2015/846219</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-3009-6579</orcidid><orcidid>https://orcid.org/0000-0002-8308-6115</orcidid><orcidid>https://orcid.org/0000-0003-3752-6033</orcidid><orcidid>https://orcid.org/0000-0001-6023-3939</orcidid><orcidid>https://orcid.org/0000-0002-5773-9012</orcidid><orcidid>https://orcid.org/0000-0002-9928-7261</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2015-01, Vol.2015 (2015), p.1-7
issn 2314-6133
2314-6141
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4322292
source Access via ProQuest (Open Access); Wiley Online Library (Open Access Collection)
subjects Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents - pharmacology
Antibiotics
Antimicrobial agents
Bacteriology
Child
Child, Preschool
Cross-Sectional Studies
Drug resistance
Drug Resistance, Microbial - drug effects
Drug Resistance, Microbial - genetics
Drug Resistance, Multiple, Bacterial - drug effects
Drug Resistance, Multiple, Bacterial - genetics
E coli
Escherichia coli
Escherichia coli - drug effects
Escherichia coli - genetics
Escherichia coli - isolation & purification
Escherichia coli Infections - drug therapy
Escherichia coli Infections - microbiology
Female
Humans
Identification and classification
Infant
Infections
Iran
Laboratories
Male
Methods
Microbial Sensitivity Tests - methods
Middle Aged
Phylogenetics
Phylogeny
Physiological aspects
Science
Studies
Surveillance
Urinary tract diseases
Urinary tract infections
Urinary Tract Infections - drug therapy
Urinary Tract Infections - microbiology
Urogenital system
Young Adult
title Phylogenetic Groups of Escherichia coli Strains from Patients with Urinary Tract Infection in Iran Based on the New Clermont Phylotyping Method
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A16%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phylogenetic%20Groups%20of%20Escherichia%20coli%20Strains%20from%20Patients%20with%20Urinary%20Tract%20Infection%20in%20Iran%20Based%20on%20the%20New%20Clermont%20Phylotyping%20Method&rft.jtitle=BioMed%20research%20international&rft.au=Khamisipour,%20Gholamreza&rft.date=2015-01-01&rft.volume=2015&rft.issue=2015&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2015/846219&rft_dat=%3Cgale_pubme%3EA458163564%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c491t-25179594a7f76699d7265e3250ec439d8a0adde6752e528a9404cc5f1e2703da3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1652320903&rft_id=info:pmid/25692147&rft_galeid=A458163564&rfr_iscdi=true